Zaino, Russell Bruce

Deanne Mazzochi is a founding member of Rakoczy Molino Mazzochi Siwik LLP. Ms. Mazzochi’s practice extends internationally, and ranges from complex litigation, due diligence and opinion counseling to regulatory proceedings and other licensing and transactional work. Her client representation primarily focuses on the intellectual property arena, with an emphasis on patent litigation, but also includes general business and commercial litigation; litigation against FDA and EPA; trademark, trade secret and copyright claims; and antitrust litigation.

Ms. Mazzochi’s trial and appellate experience includes appearances before the U.S. Court of Appeals for the Federal Circuit; various federal district courts, including the Northern District of Illinois, Eastern District of Pennsylvania, Eastern District of Virginia, Southern District of New York, District of New Jersey, District of Delaware, District of Arizona, District of Puerto Rico, Eastern District of Texas, Western District of Wisconsin, and the District of Columbia; the Illinois state courts and administrative agencies; and she further is registered to practice before the United States Patent and Trademark Office. She has represented both plaintiffs and defendants from the pre-suite investigation stage, at preliminary injunction hearings, through discovery, trial, appeallate and post-judgment proceedings.

Ms. Mazzochi also devotes a considerable amount of her practice to counseling clients regarding long-term patent strategies, including developing and protecting intellectual property rights; analyzing the scope and coverage of patents; identifying patent design-around opportunities; and implementing effective licensing strategies both in the U.S. and internationally.

The technological fields with which Ms. Mazzochi has experience encompass such diverse areas as pharmaceuticals (including active ingredient, synthesis, formulations and uses); chemistry (organic, inorganic, and industrial); biochemistry; cosmetics and skin care; food chemistry; genetics; nanotechnology; electronic circuits; electroplating; telecommunication devices; computer networks, platforms, standards and computer-driven transactions; medical devices and diagnostic tests, catalysts; polymers; photocopiers and printing presses; high tech composite wheels; bentonite clay products; other manufacturing equipment and processes; consumer products and those involving the Internet.

Ms. Mazzochi also has won several judgments in patent infringement and regulatory lawsuits brought under the Hatch-Waxman Amendments to the Federal Food, Drug and Cosmetic Act for pharmaceutical products. Her courtroom victory for Apotex Inc. before the Honorable Richard A. Posner was named a “Defense Win of the Month” in the April 2003 issue of the National Law Journal. Ms. Mazzochi also argued the appeal of this case before the Federal Circuit and obtained a final judgment of invalidity on GlaxoSmithKline’s main patent for Paxil. Along with partner William Rakoczy, Ms. Mazzochi also successfully argued the case of Apotex v. Thompson, an action against FDA that secured Apotex a market exclusivity period for a generic version of Paxil that allowed Apotex to eventually exceed $400 million dollars in sales. More recently, Ms. Mazzochi staved off a patentee’s preliminary injunction motion for a major product introduction after a two-day evidentiary hearing.

Ms. Mazzochi has been active in various bar associations, and served as a member of the Judges’ Intellectual Property Advisory Committee for the United States District Court for the District of Delaware, the influential court where the majority of patent infringement actions nationwide are filed.